Fitness & Health · Live
GFR Calculator,
kidney function estimate.
Estimate your glomerular filtration rate (eGFR) from serum creatinine, age, and sex using the CKD-EPI 2021 equation — the current clinical standard. Results include your CKD stage, kidney function percentage, and an MDRD comparison, with a colour-coded stage spectrum and full reference table.
Inputs
Lab values
Used in the CKD-EPI equation. Select whichever matches the lab order.
- CKD-EPI 2021 eGFR
- 94.6 mL/min/1.73m²
- MDRD eGFR
- 80.8 mL/min/1.73m²
- CKD stage
- G1
eGFR · CKD-EPI 2021
mL/min/1.73m²
Kidney function
≥ 90%
of normal (est.)
GFR spectrum
0 – 130+
Reference
CKD stages by eGFR (KDIGO 2024)
| Stage | eGFR range | Description |
|---|---|---|
| G1You | ≥ 90 | Normal or high kidney function |
| G2 | 60–89 | Mildly decreased kidney function |
| G3a | 45–59 | Mildly to moderately decreased |
| G3b | 30–44 | Moderately to severely decreased |
| G4 | 15–29 | Severely decreased kidney function |
| G5 | 0–14 | Kidney failure (or dialysis/transplant) |
Medical disclaimer — This calculator estimates eGFR using the CKD-EPI 2021 equation and is intended for educational purposes only. A single eGFR measurement is not sufficient to diagnose CKD. Your physician will evaluate results in the context of two or more measurements at least 3 months apart, along with urine albumin, imaging, and clinical history. Never use this tool as a substitute for professional medical advice.
Kidney function guide
What your eGFR means and how to read the results.
The glomerular filtration rate (GFR) measures how efficiently your kidneys filter waste products from the blood each minute. Because directly measuring GFR requires intravenous clearance markers, clinicians use the estimated GFR (eGFR): a calculated value derived from a simple blood test (serum creatinine) combined with demographic factors. A normal eGFR is approximately 90–120 mL/min/1.73 m² for a healthy young adult; eGFR naturally declines by roughly 1 mL/min/1.73 m² per year after age 40.
The CKD-EPI 2021 equation: the current gold standard
This calculator uses the CKD-EPI 2021 (Chronic Kidney Disease Epidemiology Collaboration) equation, published in the New England Journal of Medicine and adopted by the American Society of Nephrology, the National Kidney Foundation, and KDIGO guidelines. The 2021 update removed the race coefficient that was present in the 2009 equation, improving equity across diverse populations.
Where Scr is serum creatinine in mg/dL, κ = 0.7 (female) or 0.9 (male), and α = −0.241 (female) or −0.302 (male). The constant 0.9938^Age captures the gradual physiological decline in GFR with age.
The result is reported in mL/min/1.73 m² — normalised to a standard body surface area so that results are comparable across people of different body sizes.
What is serum creatinine?
Creatinine is a waste product produced at a constant rate by muscle metabolism. Healthy kidneys clear it from the blood at a steady rate; when kidney function declines, creatinine accumulates and blood levels rise.
Normal serum creatinine ranges (approximate):
| Group | mg/dL | μmol/L |
|---|---|---|
| Adult male | 0.74–1.35 | 65–120 |
| Adult female | 0.59–1.04 | 52–92 |
| Elderly (> 70 yr) | 0.60–1.30 | 53–115 |
| Athlete / high muscle | May be higher | due to muscle mass |
Creatinine alone is not a reliable kidney marker — a very muscular person may have a high creatinine with normal kidneys, while a frail elderly person may have normal creatinine with significantly reduced function. The CKD-EPI equation accounts for these differences through its age and sex coefficients.
CKD stages: what each level means
The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guidelines classify chronic kidney disease into six stages based on eGFR. Note that CKD is diagnosed when kidney abnormalities persist for ≥ 3 months: a single eGFR measurement below 60 does not automatically confirm CKD.
| Stage | eGFR (mL/min/1.73m²) | Description | Typical management |
|---|---|---|---|
| G1 | ≥ 90 | Normal or high | Monitor risk factors (diabetes, hypertension) |
| G2 | 60–89 | Mildly decreased | Risk factor reduction; repeat testing in 12 mo |
| G3a | 45–59 | Mild–moderate decrease | Nephrology referral recommended; manage complications |
| G3b | 30–44 | Moderate–severe decrease | Nephrology care; prepare for progressive disease |
| G4 | 15–29 | Severely decreased | Kidney replacement therapy (KRT) planning |
| G5 | < 15 | Kidney failure | Dialysis or transplant evaluation underway |
Normal eGFR decline with age
GFR decreases naturally as part of ageing, even in healthy adults with no kidney disease. The typical decline is approximately 0.75–1 mL/min/1.73 m² per year after age 40. This means a 70-year-old with an eGFR of 65 may simply have age-appropriate kidney function, not CKD.
| Age group | Average healthy eGFR | Note |
|---|---|---|
| 20–29 | ~116 | Peak function |
| 30–39 | ~107 | Modest decline begins |
| 40–49 | ~99 | Decline accelerates slightly |
| 50–59 | ~93 | Still well within normal |
| 60–69 | ~85 | Low end of G1 common |
| 70–79 | ~75 | G2 common without disease |
| ≥ 80 | ~60–70 | eGFR < 60 may be age-related |
CKD-EPI 2021 vs. MDRD — what's the difference?
This calculator shows both equations. Here is how they compare:
- CKD-EPI 2021 is more accurate at higher eGFR values (≥ 60 mL/min/1.73 m²), where MDRD tends to underestimate kidney function. It is the preferred equation by KDIGO, ASN, and NKF, and is used by most clinical labs in the United States and Europe. It is race-free (the 2021 update removed the race coefficient from the 2009 equation).
- MDRD (4-variable) was developed in 1999 and performed well in populations with known CKD (eGFR < 60). It tends to underestimate GFR in people with normal or mildly reduced function. This calculator uses the race-free MDRD variant (without the Black race coefficient).
For most clinical purposes, the CKD-EPI 2021 result is the relevant one. The MDRD value is shown for comparison only.
Common causes of reduced kidney function
A persistently low eGFR (below 60) warrants investigation for underlying causes. The most common are:
- Diabetic nephropathy: the leading cause of CKD globally; elevated blood glucose damages the kidney's filtering units over years.
- Hypertensive nephrosclerosis: chronic high blood pressure stiffens and narrows blood vessels in the kidney, reducing filtration capacity.
- Glomerulonephritis: inflammation of the glomeruli from immune-mediated diseases (IgA nephropathy, lupus nephritis, FSGS, etc.).
- Polycystic kidney disease (PKD): inherited disorder where fluid-filled cysts replace kidney tissue.
- Obstruction: kidney stones, enlarged prostate, or tumours blocking urine flow can impair filtration.
- Nephrotoxic medications: NSAIDs, aminoglycoside antibiotics, contrast dye, and certain chemotherapy agents.
How to protect and improve kidney function
For most people with mildly reduced eGFR, lifestyle measures can slow or halt progression:
- Control blood pressure. Target below 130/80 mmHg (or 120/80 in higher-risk patients per AHA guidelines). ACE inhibitors or ARBs have specific kidney-protective effects.
- Optimise blood sugar. For diabetic patients, an HbA1c target of ≤ 7% substantially reduces nephropathy progression.
- Reduce dietary sodium and protein. A low-sodium diet (≤ 2 g/day) reduces blood pressure and proteinuria. Modest protein restriction (0.8 g/kg/day) can slow CKD progression in stages 3–5.
- Avoid nephrotoxins. Limit NSAID use, ensure adequate hydration with contrast procedures, and discuss all medications with your nephrologist.
- Stay hydrated. Adequate fluid intake supports normal tubular function and reduces stone risk.
- Quit smoking and limit alcohol. Smoking independently accelerates CKD progression; heavy alcohol use raises blood pressure and IgA nephropathy risk.